In preclinical studies, XTX601 demonstrated the potential to achieve a wide therapeutic index. XTX601 demonstrated protease-dependent activation and tumor cell killing in high- and low-expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results